What is the GMP of Symbiotec Pharmalab IPO today?

The Grey Market Premium (GMP) for Symbiotec Pharmalab IPO is currently ₹185. With an upper price band of ₹988, the estimated listing price is ₹1173 per share, reflecting an expected listing gain of ~18.72%. Grey market premiums can fluctuate based on market sentiment and subscription demand.

What is the price band and lot size for Symbiotec Pharmalab IPO?

The price band for Symbiotec Pharmalab IPO is ₹938 to ₹988 per equity share. The minimum lot size is 15 shares, which requires a minimum retail application investment of ₹14,820.

What are the important dates for Symbiotec Pharmalab IPO?

Symbiotec Pharmalab IPO opens for subscription on 2026-08-24T00:00:00 and closes on 2026-08-27T00:00:00. The basis of allotment is scheduled for 2026-08-28T00:00:00, and shares are expected to list on 2026-09-01T00:00:00 on BSE, NSE.

How can I check the allotment status for Symbiotec Pharmalab IPO?

You can check Symbiotec Pharmalab IPO allotment status on the registrar's official portal (MUFG Intime India Pvt Ltd) or through the official BSE and NSE IPO allotment status pages using your PAN number or Application number.

How to apply for Symbiotec Pharmalab IPO?

Investors can apply for Symbiotec Pharmalab IPO online through ASBA (Application Supported by Blocked Amount) via their internet banking account, or via UPI using authorized stockbroking platforms like Zerodha, Groww, Angel One, and Upstox.

When does the Symbiotec Pharmalab IPO open and close?

The IPO opens on 24 Aug 2026, and closes on 27 Aug 2026.

What is Symbiotec Pharmalab IPO price band?

The issue price band is ₹938.00 to ₹988.00 per equity share.

What is the Symbiotec Pharmalab IPO lot size?

The minimum lot size is 15 shares per application.

What is the Symbiotec Pharmalab IPO allotment date?

The allotment is scheduled on 28 Aug 2026.

Symbiotec Pharmalab IPO Details - Dates, Price Band, Issue Size

All IPOs

Issue Size

1757.00 Cr

Price Band

₹938.00 - ₹988.00

Lot Size

15 Shares

Min Investment

₹14,820

GMP

₹185

Subscription

52.89x

₹92,952.26 Cr

24 Aug 2026

IPO Opens

COMPLETED

27 Aug 2026

IPO Closes

COMPLETED

28 Aug 2026

Basis of Allotment

COMPLETED

31 Aug 2026

Refunds

COMPLETED

31 Aug 2026

Demat Credit

COMPLETED

01 Sept 2026

Listing

COMPLETED

IPO Timeline

IPO OpensDONE

24 Aug 2026

IPO ClosesDONE

27 Aug 2026

Basis of AllotmentDONE

28 Aug 2026

RefundsDONE

31 Aug 2026

Demat CreditDONE

31 Aug 2026

ListingDONE

01 Sept 2026

About Symbiotec Pharmalab IPO

Symbiotec Pharmalab IPO open date is August 24, 2026 and the IPO will close on August 27, 2026. Symbiotec Pharmalab IPO is a Book built Issue. The company to raise around ₹1757 crores via IPO that comprises fresh issue of ₹150 crores and offer for sale up to 1,62,65,181 equity shares with face value of ₹2 each.

Symbiotec Pharmalab IPO price band is ₹938 to ₹988 per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Symbiotec Pharmalab IPO to list on BSE, NSE on September 1, 2026. The allotment of Symbiotec Pharmalab IPO date is August 28, 2026.

The company reported revenue of ₹872.26 crores in 2026 against ₹755.98 crores in 2025. The company reported profit of ₹109.90 crores in 2026 against profit of ₹96.79 crores in 2025. As per the financials, the IPO investors should apply the IPO for a long term.

IPO Details

Symbiotec Pharmalab IPO Details and Specifications
IPO Date	24 Aug 2026 to 27 Aug 2026
Face Value	₹2 Per Share
Price Band	₹938.00 - ₹988.00
Lot Size	15 Shares
Total Issue Size	Approx 1757.00 Cr 1,77,86,442 Equity Shares
Fresh Issue	Approx 150.00 Cr 15,21,261 Equity Shares
Offer for Sale	Approx 1607.00 Cr 1,62,65,181 Equity Shares
Retail Portion	35%
Sale Type	Offer for sale
Issue Type	Book-Building IPO
Listing Date	01 Sept 2026
Listing At	BSE & NSE
Share Holder Quota	Yes
Total Subscription Amount	₹92,952.26 Cr

Issue Reservation

Investor Category	Shares Offered	% Net Issue
QIB	88,76,516	50.00%
- Anchor	53,25,909	0.00%
- QIB (Ex. Anchor)	35,50,607	0.00%
NII	26,62,956	15.00%
- bNII > ₹10L	17,75,304	0.00%
- sNII < ₹10L	8,87,652	0.00%
Retail	62,13,563	35.00%
Employees	33,407	0.00%
Total	1,77,86,442	100.00%

IPO Lot Size

Application	Lots	Shares	Amount
Individual investors (Retail) (Min)	1	15	₹14,820
Individual investors (Retail) (Max)	13	195	₹1,92,660
S-HNI (Min)	14	210	₹2,07,480
S-HNI (Max)	67	1,005	₹9,92,940
B-HNI (Min)	68	1,020	₹10,07,760

About Company

Symbiotec Pharmalab is a pharmaceutical and biotechnology company with over 30 years of experience. It mainly manufactures Corticosteroid and Steroidal Hormone APIs, which are important ingredients used to make medicines.

The company has grown from a small laboratory-scale steroid manufacturer into a fully integrated global company. In FY2025, Symbiotec had a strong share of the global market for these APIs and was the only Indian and global company present across the top 10 categories in this market.

In FY2025, they were a global leader by volume in the production of Corticosteroid and Steroidal-Hormone Active Pharmaceutical Ingredients (APIs).

Contact Details

Symbiotec Pharmalab Ltd.

385/2,

Pigdamber, Rau,

Mhow,

Indore, Madhya Pradesh, 453331

+91 731 667 6405

secretarial@symbiotec.com

Visit Website

Registrar

MUFG Intime India Pvt Ltd

022-49186000

symbiotecpharmalab.ipo@in.mpms.mufg.com

Lead Managers

Avendus Capital Pvt Ltd

JM Financial Ltd

Motilal Oswal Investment Advisors Ltd

Nomura Financial Advisory And Securities (India) Pvt Ltd

Day-wise GMP Trend

Date & Time	GMP (₹)	Est. Listing Price	Est. Gain (%)	Est. Profit / Lot (₹)
01-Sep-2026 12:00 PM	+₹185	₹1173	+18.72%	₹2,775
31-Aug-2026 12:00 PM	+₹205	₹1193	+20.75%	₹3,075
30-Aug-2026 12:00 PM	+₹260	₹1248	+26.32%	₹3,900
28-Aug-2026 12:00 PM	+₹270	₹1258	+27.33%	₹4,050
27-Aug-2026 12:00 PM	+₹275	₹1263	+27.83%	₹4,125
26-Aug-2026 12:00 PM	+₹333	₹1321	+33.70%	₹4,995
25-Aug-2026 12:00 PM	+₹340	₹1328	+34.41%	₹5,100
24-Aug-2026 12:00 PM	+₹388	₹1376	+39.27%	₹5,820
22-Aug-2026 12:00 PM	+₹380	₹1368	+38.46%	₹5,700
21-Aug-2026 12:00 PM	+₹320	₹1308	+32.39%	₹4,800
20-Aug-2026 12:00 PM	+₹260	₹1248	+26.32%	₹3,900

Subscription Status

Category	Subscription (x)	Shares Offered	Shares bid for	Total Amount (₹ Cr)
Anchor	1.00x	53,25,909	53,25,909	₹526.20 Cr
QIB (Ex. Anchor)	181.20x	35,50,607	64,33,59,195	₹63,563.89 Cr
NII	77.56x	26,62,956	20,65,35,120	₹20,405.67 Cr
bNII > ₹10L	87.34x	17,75,304	15,50,46,495	₹15,318.59 Cr
sNII < ₹10L	58.01x	8,87,652	5,14,88,625	₹5,087.08 Cr
Retail	13.69x	62,13,563	8,50,47,105	₹8,402.65 Cr
Employees	16.32x	33,407	5,45,055	₹53.85 Cr
Total	52.89x	1,77,86,442	94,08,12,384	₹92,952.26 Cr

Objects of the Issue

01 Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company : 112.50 Cr
02 General corporate purposes : 29.53 Cr
03 Issue Expenses : 105.02 Cr

Company Financials

Period Ended	31 MAR 2026	31 MAR 2025	31 MAR 2024
Total Income	872.26	755.98	723.33
Profit After Tax	109.90	96.79	100.06
EBITDA	231.97	206.11	177.04
NET Worth	1158.64	821.15	720.68
Reserves and Surplus	1145.95	810.03	709.54
Total Borrowing	387.91	540.92	247.21

Amount in ₹ Crore

IPO Valuation - KPI

KPI	31 Mar 2025
ROCE	11.80%
Return on Net Worth (RoNW)	11.79%
PAT Margin	12.80%
EBITDA Margin	27.26%
Net Asset Value (NAV)	₹150.17
Earning Per Share (EPS)	₹17.10
Price/Earning P/E Ratio	57.78x

Peer Comparison

Company Name	EPS (₹)	P/E (x)	NAV (₹)	RoNW (%)	Income (₹ Cr)
Laurus Labs Limited	16.47	109.36	-	16.80	6,812.90
Cohance Lifesciences Limited	4.69	95.02	-	7.00	2,268.55
Divi’s Laboratories Limited	96.75	87.80	631.00	16.50	10,560.00
Concord Biotech Limited	24.78	61.07	-	14.00	1,054.90

Promoters and Holding Pattern

Anil Satwani, Kashish Satwani, Sushil Satwani and Satwani Holdings LLP. is the company's promoter of Symbiotec Pharmalab.

Particular	Pre IPO	Post IPO
Promoter and Promoter Group	36.39%	33.28%
Others*	63.61%	66.72%

Frequently Asked Questions (FAQ)

Comments0

Join the discussion

Please sign in to leave a comment or reply.

Sorted by

Loading IPO Details...

About Symbiotec Pharmalab IPO

IPO Details

Symbiotec Pharmalab IPO Details and Specifications
IPO Date	24 Aug 2026 to 27 Aug 2026
Face Value	₹2 Per Share
Price Band	₹938.00 - ₹988.00
Lot Size	15 Shares
Total Issue Size	Approx 1757.00 Cr 1,77,86,442 Equity Shares
Fresh Issue	Approx 150.00 Cr 15,21,261 Equity Shares
Offer for Sale	Approx 1607.00 Cr 1,62,65,181 Equity Shares
Retail Portion	35%
Sale Type	Offer for sale
Issue Type	Book-Building IPO
Listing Date	01 Sept 2026
Listing At	BSE & NSE
Share Holder Quota	Yes
Total Subscription Amount	₹92,952.26 Cr

Investor Category

Shares Offered

% Net Issue

QIB

88,76,516

50.00%

- Anchor

53,25,909

0.00%

- QIB (Ex. Anchor)

35,50,607

0.00%

NII

26,62,956

15.00%

- bNII > ₹10L

17,75,304

0.00%

- sNII < ₹10L

8,87,652

0.00%

Retail

62,13,563

35.00%

Employees

33,407

0.00%

Total

1,77,86,442

100.00%

Application

Lots

Amount

Individual investors (Retail) (Min)

₹14,820

Individual investors (Retail) (Max)

195

₹1,92,660

S-HNI (Min)

210

₹2,07,480

S-HNI (Max)

1,005

₹9,92,940

B-HNI (Min)

1,020

₹10,07,760

About Company

In FY2025, they were a global leader by volume in the production of Corticosteroid and Steroidal-Hormone Active Pharmaceutical Ingredients (APIs).

Contact Details

Symbiotec Pharmalab Ltd.

385/2,

Pigdamber, Rau,

Mhow,

Indore, Madhya Pradesh, 453331

+91 731 667 6405

secretarial@symbiotec.com

Visit Website

Date & Time

GMP (₹)

Est. Listing Price

Est. Gain (%)

Est. Profit / Lot (₹)

01-Sep-2026 12:00 PM

+₹185

₹1173

+18.72%

₹2,775

31-Aug-2026 12:00 PM

+₹205

₹1193

+20.75%

₹3,075

30-Aug-2026 12:00 PM

+₹260

₹1248

+26.32%

₹3,900

28-Aug-2026 12:00 PM

+₹270

₹1258

+27.33%

₹4,050

27-Aug-2026 12:00 PM

+₹275

₹1263

+27.83%

₹4,125

26-Aug-2026 12:00 PM

+₹333

₹1321

+33.70%

₹4,995

25-Aug-2026 12:00 PM

+₹340

₹1328

+34.41%

₹5,100

24-Aug-2026 12:00 PM

+₹388

₹1376

+39.27%

₹5,820

22-Aug-2026 12:00 PM

+₹380

₹1368

+38.46%

₹5,700

21-Aug-2026 12:00 PM

+₹320

₹1308

+32.39%

₹4,800

20-Aug-2026 12:00 PM

+₹260

₹1248

+26.32%

₹3,900

Symbiotec Pharmalab IPO Details

About Symbiotec Pharmalab IPO

IPO Details

Issue Reservation

IPO Lot Size

About Company

Day-wise GMP Trend

Objects of the Issue

Company Financials

IPO Valuation - KPI

Peer Comparison

Promoters and Holding Pattern

Frequently Asked Questions (FAQ)

When does the Symbiotec Pharmalab IPO open and close?

What is Symbiotec Pharmalab IPO price band?

What is the Symbiotec Pharmalab IPO lot size?

What is the Symbiotec Pharmalab IPO allotment date?

What is the Symbiotec Pharmalab IPO listing date?

What is the minimum investment required in Symbiotec Pharmalab IPO?

Join the discussion

Symbiotec Pharmalab IPO Details

About Symbiotec Pharmalab IPO

IPO Details

Issue Reservation

IPO Lot Size

About Company

Day-wise GMP Trend

Objects of the Issue

Company Financials

IPO Valuation - KPI

Peer Comparison

Promoters and Holding Pattern

Frequently Asked Questions (FAQ)

When does the Symbiotec Pharmalab IPO open and close?

What is Symbiotec Pharmalab IPO price band?

What is the Symbiotec Pharmalab IPO lot size?

What is the Symbiotec Pharmalab IPO allotment date?

What is the Symbiotec Pharmalab IPO listing date?

What is the minimum investment required in Symbiotec Pharmalab IPO?

Join the discussion